Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Owen N. Witte currently holds 191,082 shares of Allogene Therapeutics, Inc. (ALLO), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Owen N. Witte has been a net seller of ALLO stock. They have purchased $270.0K and sold $3.7M worth of shares.
Owen N. Witte's most recent insider trade was on Jun 5, 2024, when they sold 191,082 shares at $0.00 per share.
Owen N. Witte serves as Executive at Allogene Therapeutics, Inc. (ALLO). They have executed 24 insider transactions totaling $4.0M over their tenure at the company.
Owen N. Witte holds the position of Executive at Allogene Therapeutics, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 9 years and currently hold a stake valued at $0.
Owen N. Witte has shown a selling trading pattern, with $270.0K in total purchases and $3.7M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Owen N. Witte was on Oct 3, 2017, when they sold $10.5M worth of KITE shares. This transaction involved 58,535 shares at $180.00 per share.
Owen N. Witte currently owns 191,082 shares of Allogene Therapeutics, Inc. (ALLO), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Owen N. Witte's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Owen N. Witte has 24 Form 4 filings on record as an insider at Allogene Therapeutics, Inc..
Set alerts for Owen N. Witte and 40,000+ other insiders.